
The Science I Would Be Doing if I Weren't in ICE Detention
When I moved to America from Russia to join a biology lab at Harvard Medical School in 2023, it felt as if I found my dream job. America was a paradise for science. Everything was flourishing. There was freedom of discourse; conferences, seminars. It was nothing like the environment I had left behind in Russia, where international sanctions meant there weren't enough supplies to do experiments and I once declined a job offer that was contingent on me no longer protesting the war in Ukraine. After I was arrested for taking part in a protest, I fled the country, knowing that I could not continue to live or work as a scientist there.
My background is in bioinformatics, a field that uses computational tools to understand biology. In my lab at Harvard, I worked with a microscope that we called NoRI (short for Normalized Raman Imaging). This microscope, which was created in our lab, is the only one like it in the world. What makes it unique is its ability to measure the chemical makeup of cells to an astonishing and novel degree of precision, offering new insights into disease and aging that could one day pave the way for healthier life spans and treatments for diseases like Alzheimer's and cancer.
There is so much beauty in what we can learn through science, in how complicated life is, and in trying to understand how it works. It's what motivates me to wake up every morning.
I haven't been in my lab or worked with my microscope since February, when I was detained by U.S. Immigration and Customs Enforcement as I was returning to Boston from a vacation in France. At Logan International Airport, I did not complete a customs declaration for frog embryos (for use in our lab's research) in my luggage. I'm told this would normally result in a warning or a fine. Instead, my visa was revoked and I was sent to a detention center in Louisiana, where I have spent the past three months with roughly 100 other women. We share one room with dormitory-style beds.
I'm used to spending up to 12 hours a day in the lab, talking with colleagues about tricky scientific questions and fine-tuning the algorithms used for NoRI. At the detention center, there is no access to computers and six phones are shared among all of us. The calls cost $5 for 15 minutes, at which point they cut off. It's constantly noisy and cold. Fortunately, my beautiful colleagues have mailed me academic articles and books (I'm reading a wonderful one now about biochemistry called 'Transformer' that I recommend to everyone).
I've asked a colleague to share some of the images from NoRI with The Times. Maybe if people see them, they will understand why I want to get back to work. Until now, no one outside our lab has seen these images, which are of tissue samples taken from mice and rats that we hope will provide greater understanding of how organs age and diseases develop in the body.
A traditional light microscope, like one you might find in a high school biology class, works by shining light through lenses to magnify a sample.
Our microscope is different. It takes advantage of the fact that each type of molecule has its own unique frequency of vibration. If we pass a specialized laser through a sample, we can measure how it interacts with these vibrations and generate a detailed image that shows the kinds of molecules inside.
Because of the way our microscope works, we don't have to use dyes that can make samples more visible but commonly damage them. That may seem like a minor point, but it's utterly revolutionary. Take lipids, types of fat in the body. It's almost impossible to study lipids through traditional microscopes because they are so easily destroyed while preparing the sample.
The accumulation of fat in tissues plays a crucial role in diabetes, heart disease, kidney disease and cancers. The fact that scientists haven't been able to measure lipids accurately before now has made it harder to understand these diseases. With NoRI, our lab is uncovering new hallmarks of diseases, learning about the role of lipids and cholesterol in cancer development and gaining new knowledge about cells in the brain and the development of Alzheimer's disease.
Our next project with NoRI — which we started just before I was detained — is to use the microscope to produce what we are calling an 'atlas of aging.' Everyone takes aging for granted and knows the signs of it, but no one really understands why it happens. At our Harvard lab, we plan to analyze many different samples of organs at different ages to understand how each organ changes over time. Images of kidneys from young and old rats have revealed new features of how kidneys age. The goal is to use these discoveries to improve the quality of life of older people.
My colleagues tell me that since my detention, the work with NoRI has ground to a halt. Without me there to help, the lab has been unable to analyze the image data that the microscope generates.
The political environment in Russia made it hard to do science because everything was unpredictable. The war in Ukraine affected scientists' ability to get funding and materials; we worried that our male colleagues might be conscripted. That type of uncertainty is incompatible with science, which requires the ability to plan what type of experiments and research you will do a year into the future. I fear that if I return to Russia I will be arrested.
I am hesitant to comment broadly on what it's like for scientists now in America because I have only limited information about what is going on outside of this detention center. What I do know is that my colleagues, many of whom are, like me, foreign scientists, are terrified of being detained or having their visa status revoked.
On Wednesday a federal judge in Vermont will hear a petition challenging my detention. I am not able to attend the hearing, but my lawyer, as well as colleagues and friends, will be there.
During my time in detention I have been learning about immigration in America. I'm meeting all sorts of people with unique stories. One young woman here in ICE detention has been in the United States for more than a dozen years; her fiancée is an American citizen, but her next court date, in which she could finally be released on parole, is not until October. Another woman, who was seeking political asylum, was just deported; her daughter has legal status in America, and they don't know when or if they'll meet again. The people I've spent time with are not dangerous criminals. They are friendly, kind people.
I hope that the judge rules Wednesday that I can be released, so I can return to my lab. There is a data set that I'm halfway finished analyzing. I want to go home and finish it.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
37 minutes ago
- New York Times
MLB teams most likely to be sellers at trade deadline — and the players they could shop
With the calendar flipping to June, the MLB trade deadline is less than two months away. That leaves about eight weeks for contending teams to make deals to acquire players to improve their rosters, and eight weeks for non-contenders to start to rebuild for 2026 and beyond. Of course, there's a lot of baseball to be played between now and the July 31 deadline, but the landscape is starting to take shape. So let's begin to take stock, with the caveat that there will be changes along the way that no one can foresee. Advertisement Below are the nine teams that I currently believe will become 'sellers' at this year's trade deadline, but keep in mind several other teams that remain in contention now will join this list by the All-Star break (or shortly thereafter). It's pretty obvious, based on their records and low expectations entering the season, that the Rockies, White Sox, Pirates, Athletics, Marlins and Angels will be selling. Meanwhile, the Nationals, although hovering around .500, are a year away from legitimately contending, so they, too, need to focus on future seasons, and I expect them to ultimately be sellers. That leaves two surprise sellers on my initial list: the Orioles and Diamondbacks. At the start of the season, I thought both would make the playoffs as wild-card teams, but they've underperformed. Their pitching staffs have been riddled with injuries and just haven't delivered. The Orioles' staff ranks 28th in the majors with a 5.27 ERA, while the D-Backs' pitchers haven't fared much better (24th, 4.81 ERA). Baltimore is in worse shape, in the standings and overall — Arizona's offense ranks fourth in MLB in OPS and fifth in runs scored — but both teams have dug holes and, barring a change in fortune, it's probably best they become sellers. As the Orioles and Diamondbacks weigh whether to sell, they'll consider that they could become the headliners of this trade deadline in a sellers' market. They could both make shrewd trade deadline deals, then enter the offseason a key free agent or two away from contending again next year. Since most of this year's likely sellers don't have a lot of talent to trade, Baltimore and Arizona could take advantage of the lackluster market. The Orioles could dangle impact bat Ryan O'Hearn (175 OPS+), elite center fielder Cedrick Mullins and veteran starting pitchers such as Zach Eflin and Tomoyuki Sugano. The Diamondbacks, particularly if they learn ace Corbin Burnes will miss significant time with an elbow injury, could make starting pitchers Zac Gallen and Merrill Kelly available in trade talks and could put first baseman Josh Naylor on the trade market too. All seven of those players are impending free agents. Advertisement It can be a tough and unpopular call to sell in these situations, and both teams have time to make that decision. Both expected to play in the postseason this year, but if they instead play at the trade deadline, then next year they could be in a much stronger position for October baseball. For now, here is my take on the nine teams that I believe will be sellers at the trade deadline, along with the players they could shop or contenders would covet. Starting pitchers: The Rockies don't have much to trade from their majors-worst rotation, but a team could take a chance on Kyle Freeland, who has posted a 4.29 ERA over six road starts this season. Freeland, 32, is making $16 million this year and will earn $16 million in 2026, plus has a $17 million vesting option for 2027 that's triggered if he reaches 170 innings next year. He's a back-of-the-rotation lefty who could benefit from a change of scenery and not having to pitch half his games in Coors Field. Relief pitchers: Colorado could dangle its two closers, Zach Agnos and Seth Halvorsen, or even set-up relievers such as Jake Bird and Victor Vodnik. The historically bad Rockies are in no position to hang onto relievers if they could be dealt for either starting pitching prospects or everyday position players at any level. Catchers/Infielders: Veteran third baseman Ryan McMahon is a trade candidate with the positional flexibility to also play second base. He's signed through 2027 and will make $32 million over the final two years of the contract. However, he has struggled this year at the plate (83 OPS+) and just doesn't have the trade value he possessed in the past four years, when he averaged 20-plus home runs per season. Shortstop Ezequiel Tovar is their most valuable infielder, but he's an important building block and not going anywhere. Advertisement Outfielders/DH: Their most valuable outfielder, center fielder Brenton Doyle, is having a down year, but the two-time Gold Glove Award winner is a keeper for the long term. Jordan Beck has some value, but the second-year major leaguer is unlikely to be moved. Most likely to be traded: LHP Kyle Freeland, 3B Ryan McMahon, RHP Seth Halvorsen Starting pitchers: The White Sox are developing a young rotation that includes Shane Smith, Sean Burke, Davis Martin and Jonathan Cannon — none of whom is expected to get traded. Adrian Houser, the lone healthy veteran in their rotation, could be dealt to a team looking for back-of-the-rotation depth. Relief pitchers: Steven Wilson will probably be traded. The veteran righty will be arbitration-eligible for two more years. He's allowed only one run over his past seven appearances and has a 2.16 ERA on the season. Catchers/Infielders: Miguel Vargas is the only infielder the White Sox could get nibbles on. The ex-Dodger has had a solid season at third base with eight homers, 15 doubles and 26 RBIs, and he has some positional flexibility. However, Vargas is only 25 years old and Chicago is not looking to trade him. Outfielders/DH: Luis Robert Jr. is their top trade chip, but he's had a brutal start to the season, batting just .177 with a .266 on-base percentage. He does have five homers and 21 stolen bases and plays plus defense in center field, but — unless he starts raking in June and July — the White Sox's asking price will have to come way down. Most likely to be traded: CF Luis Robert Jr., RHP Adrian Houser and RHP Stephen Wilson Starting pitchers: The Pirates can shop veteran lefty Andrew Heaney, an impending free agent. He has posted a 3.39 ERA over 12 starts and can help eat innings at the back of a rotation. They are less likely to trade from the rest of their rotation, which includes ace Paul Skenes, Mitch Keller and Bailey Falter along with Jared Jones, who underwent season-ending elbow surgery. Advertisement Relief pitchers: Pittsburgh has several relievers to trade including closers Dennis Santana and David Bednar, who are a combined 11-for-11 in save opportunities this season, and veteran lefty relievers Caleb Ferguson and Ryan Borucki. Catchers/Infielders: Second baseman Adam Frazier and shortstop Isiah Kiner-Falefa can be shopped, but they would be merely extra players on a contending team rather than starting, like they do for Pittsburgh. The Pirates could explore trading third baseman Ke'Bryan Hayes, but he's having another poor offensive season and his power has never arrived. Hayes is signed through 2029, and although he'll make an affordable $7.5 million annually over the next four years and deliver strong defense, most teams wouldn't want his contract. Outfielders/DH: It's unlikely the Pirates trade any of their outfielders. Oneil Cruz, their best player, isn't going anywhere. Bryan Reynolds is having a down year and is owed more than $15 million per year through 2030. DH Andrew McCutchen is expected to finish his career as a Pirate. Most likely to be traded: LHP Andrew Heaney, RHP Dennis Santana, 2B/OF Adam Frazier Starting pitchers: The A's could listen to inquiries on lefty Jeffrey Springs, whom they acquired in a trade with the Rays in the offseason, and fellow southpaw JP Sears; both have multiple years of team control. It's not like they'd want to move either, but they'd at least listen in case they get a compelling offer. Relief pitchers: Every contender would want the A's closer, Mason Miller, but there is no indication they'll trade him. Don't be surprised if they at least listen on Miller, who is under team control through 2029, as he could bring back a franchise-changing haul in prospects. It's more likely they move righty Tyler Ferguson, who has a 3.76 ERA over 27 appearances. Catchers/Infielders: The A's have a solid young infield but they're movable pieces are backup players such as Miguel Andujar (strained oblique), Luis Urías or Gio Urshela (hamstring strain). However, two of the three are on the injured list and none of them has much trade value. Advertisement Outfielders/DH: It's unlikely an outfielder or DH is moved. Most likely to be traded: LHP Jeffrey Springs, RHP Tyler Ferguson, 3B/OF Miguel Andujar Starting pitchers: After losing their best starter (Corbin Burnes) in free agency to the Diamondbacks last offseason and their next best starter (Grayson Rodriguez) to the IL this season with elbow inflammation, the Orioles will need to listen to trade offers on the rest of their rotation to begin their reboot in earnest. Tomoyuki Sugano is having a solid first year in MLB (3.23 ERA over 11 starts), but he's 35 years old. Zach Eflin will be a free agent at season's end, so dealing the righty for prospects and then trying to re-sign him in the offseason probably makes sense. Also, despite his poor start to the season, if Charlie Morton (6.20 ERA) can put together a string of good outings, he's another veteran who could be traded. Relief pitchers: The Orioles don't want to move their impact closer, Félix Bautista, who is under team control through 2027, but they'll at least listen to see if they get an overwhelming offer. Otherwise, veterans such as righty Seranthony Domínguez and lefty Gregory Soto, both impending free agents, should be traded. The Orioles might even listen to inquiries on Yennier Cano and Keegan Akin to see if some team will offer solid pitching prospects in return. They must rebuild their pitching staff with younger arms. Catchers/Infielders: The Orioles can shop both of their first base/DH power bats in Ryan O'Hearn and Ryan Mountcastle. O'Hearn, who is slashing .329/.416/.535 with nine homers and 22 RBIs, has the most trade value of any Orioles player. He will be a free agent after this season. Mountcastle is on the IL with a strained hamstring but his raw right-handed power still has some value. That said, his home run totals have declined every year since 2021. Outfielders/DH: Cedric Mullins is also on the IL with a strained hamstring but should be healthy by the trade deadline. An elite defensive center fielder, Mullins is having a solid offensive year with 10 homers, eight steals and a 123 OPS+ in 50 games. He will be a free agent after the season. Most likely to be traded: 1B/DH Ryan O'Hearn, CF Cedric Mullins, RHP Zach Eflin Advertisement Starting pitchers: In March, Sandy Alcantara was expected to be a headliner of this year's trade deadline, but he hasn't been able to regain his Cy Young Award form of 2022 after returning from Tommy John surgery. It would be foolish for the Marlins to swap Alcantara with his ERA so high (8.47 ERA) and trade value so low. They'll need to wait until the offseason or next year's deadline — he's under team control through 2027 — before they consider trading him. The rest of the Marlins' rotation consists of 25- to 27-year-old starters like Max Meyer, Ryan Weathers and Edward Cabrera who are building blocks. That leaves veteran Cal Quantrill as the only likely trade chip from this group, but he has a 5.84 ERA over 11 starts. Relief pitchers: The Marlins could listen to offers on some of their relievers including Ronny Henriquez (2.20 ERA, 12.6 strikeouts per nine innings), Jesus Tinoco (5.12 ERA, four saves), Calvin Faucher (4.95 ERA, four saves) and Anthony Bender (1.52 ERA). Catchers/Infielders: They really don't have anything to trade in the infield as it is filled with young, developing players with minimal service time. Outfielders/DH: The same can be said for the outfield and DH positions, though right fielder Jesús Sánchez is an exception. He will be arbitration-eligible in 2026 and is a left-handed bat (109 OPS+) some contending teams could chase. Most likely to be traded: RF Jesús Sánchez, RHP Cal Quantrill, RHP Anthony Bender Starting pitchers: The Angels could shop their best starter, Yusei Kikuchi (3.06 ERA), but it's unlikely they trade the lefty after signing him to a three-year, $63 million deal to headline their offseason. They could dangle José Soriano or Tyler Anderson, both of whom have ERAs under 3.90 this season. Anderson, 35, will be a free agent after this season. Advertisement Relief pitchers: Kenley Jansen is 12-for-12 in save opportunities and should have some trade value. Other relievers who could get moved include Ryan Zeferjahn and Brock Burke. Catchers/Infielders: Veteran catcher Travis d'Arnaud could get traded to a contender as could versatile infielder Luis Rengifo and maybe even third baseman Yoán Moncada (IL). D'Arnaud is signed through 2026, while the other two are impending free agents. Outfielders/DH: Left fielder Taylor Ward could bring back the best prospect package. He has 16 homers and 11 doubles with a .271 on-base percentage and is under team control through next year. Jorge Soler and his power bat could be traded again, and it probably makes sense for the Angels to get out of his contract ($16 million per year through 2026) if possible. Most likely to be traded: LF Taylor Ward, RHP Kensley Jansen, LHP Tyler Anderson Starting pitchers: Veterans Michael Soroka and Trevor Williams could get moved if they have a strong run of starts in June and July. Both are back-of-the-rotation inning-eaters at this point. Relief pitchers: The Nationals didn't trade closer Kyle Finnegan at last year's trade deadline and then were able to re-sign him in the offseason on an affordable one-year contract. Finnegan has 16 saves and a 2.61 ERA, and I'll be surprised if he isn't traded at this year's deadline. Lefty Andrew Chafin, who has been traded at the deadline two years in a row, could be on the move again. He has a 2.00 ERA in 12 appearances and left-handed batters are hitting .200 against him. Catchers/infielders: The only infielders who could get traded are utility types such as Amed Rosario and Paul DeJong, the latter of whom is on the IL with a broken nose. Outfielders/DH: They won't trade from their young outfield of James Wood in left, Robert Hassell III in center and Dylan Crews in right, although if center fielder Jacob Young comes back healthy from a sprained shoulder, he could get moved. He's a plus defender who can really run in center, ranking in the 94th percentile in sprint speed and the 85th percentile in outs above average (defensive range). In addition, Josh Bell could be traded again, but he'll have to perform much better in June and July for anyone to have interest. Advertisement Most likely to be traded: RHP Kyle Finnegan, CF Jacob Young, LHP Andrew Chafin Starting pitchers: Corbin Burnes underwent an MRI after exiting Sunday's game with an elbow issue. If the Diamondbacks get bad news on Burnes, they could become surprise sellers at the trade deadline, and if that happens, they could trade Zac Gallen and Merrill Kelly as both are impending free agents. Gallen is having a subpar year — he's logged a 5.54 ERA, more than two runs over his career mark — and would have to pitch much better over his next five to six starts for the Diamondbacks to get anything close to his value if he were pitching at his accustomed level. Relief pitchers: The Diamondbacks could shop veteran relievers such as Shelby Miller, Jalen Beeks, Ryan Thompson and Kendall Graveman, all of whom are in their 30s. Catchers/Infielders: Arizona made a great trade in the offseason to land first baseman Josh Naylor, but if they pivot to selling, he will probably get dealt again given he's in his free-agent walk year. Naylor, 27, would be an excellent fit for the Seattle Mariners or Cincinnati Reds. Outfielders/DH: Randal Grichuk could be dealt to a team that needs an extra outfielder; he has some power and has learned how to come off the bench successfully. Most likely to be traded: RHP Zac Gallen, 1B Josh Naylor, RHP Shelby Miller (Top image photos: Ryan O'Hearn: Winslow Townson / Getty Images; Taylor Ward: Ezra Shaw / Getty Images)


New York Times
38 minutes ago
- New York Times
Deportation flights accelerate, reaching a high under Trump.
President Trump's mass deportation plans appear to have accelerated in May, with Immigration and Customs Enforcement flying more removal flights than in any other month since he took office, according to public flight data collected by Tom Cartwright, an immigration advocate who tracks ICE flights. The latest government data shows the number of daily deportees averaged about 850 per day in the first two weeks of May, following a gradual climb since early March. The increasing pace of ICE removal flights through the month suggests deportation numbers could continue to trend upward in June.


Fox News
38 minutes ago
- Fox News
Trump criticizes Rand Paul over tax bill opposition: 'Votes no on everything'
President Donald Trump on Tuesday criticized Sen. Rand Paul, R-Ky., for opposing his "big, beautiful bill." "Rand Paul has very little understanding of the BBB, especially the tremendous GROWTH that is coming. He loves voting 'NO' on everything, he thinks it's good politics, but it's not. The BBB is a big WINNER!!!" Trump wrote on TRUTH Social. The president added, "Rand votes NO on everything, but never has any practical or constructive ideas. His ideas are actually crazy (losers!). The people of Kentucky can't stand him. This is a BIG GROWTH BILL!" Paul is among a group of at least four Republican senators who have expressed apprehension over Trump's "big, beautiful bill" due to the budget package's projected increase in the national debt. The White House has framed the bill as a solution to four years of failures under former President Joe Biden. Sens. Ron Johnson of Wisconsin, Rick Scott of Florida, and Mike Lee of Utah, three other Republicans in the upper chamber, have also shared concerns about the bill's fiscal implications. Paul told Breitbart News on Monday that while he believes the left is "adrift," most Republicans are shying away from intra-party debates on certain issues, similarly to how Democrats acted after former President Barack Obama's re-election win. Paul reportedly said he supports "a lot" of Trump's budget package but disagrees with "the additional $5 trillion in debt" the senator claims is attached to the bill. "That's a hard place for me as I support much of what's in the bill, tax cuts, spending cuts, plus more spending cuts if we can get them. But I can't reconcile myself to adding $5 trillion in debt, raising the debt ceiling," Paul said. The senator told Breitbart the debt is going to be $2.2 trillion this year and Republicans have largely continued Biden-era spending levels. "They're anticipating $5 trillion in two years, and that means next year's deficit that some people are saying it's going to grow to over $3 trillion a year again," Paul said. The senator separately expressed to the Associated Press that he told Trump this would be the first time in recent history that Republicans would "own" the debt ceiling if an increase of the nation's debt limit was included in the GOP's sweeping tax and spending package. Paul reportedly added in the Breitbart interview that his opposition to portions of the "big, beautiful bill" are meant to preserve the Department of Government Efficiency (DOGE)'s progress down the road. "My fear is that when this bill passes that the ramifications a year out, two years out, will be, 'My goodness, what happened to DOGE? What happened to the spending cuts? Why is the deficit so big still?'" he said. "So I am working very hard to make sure there is still at least a part of the party — and it doesn't have to be anti-Donald Trump because I'm for him in so many ways — but it also means people still have to stand up and present their own ideas of what they're for." "I do support President Trump and I support most of the bill," Rand also wrote on X, explaining his position. "I'm his biggest defender on foreign policy. But at the same time I want conservative government so I have to fight for what I believe in." Trump and Senate Majority Leader John Thune, R-South Dakota, met at the White House at a critical moment Monday as senators returned to begin negotiations over the president's big tax breaks and spending cuts package. Thune said that GOP senators are "on track" to have the package approved by their July 4 deadline. But Thune also acknowledged the long road ahead as senators grind through private talks over changes to put their own stamp on the House-passed bill. Thune told the Senate floor on Monday that Republicans' priority is "extending tax relief for hardworking Americans and strengthening our border, energy, and national security." Sen. Josh Hawley, R-Mo., meanwhile, says Trump told him in a call he "wants to make sure" the Senate doesn't cut Medicaid benefits, according to the AP. The Missouri Republican has been working to strip steep healthcare cuts from the House bill, beyond work requirements for some aid recipients. Hawley said Trump told him the senators could instead raise revenue by closing the so-called carried interest tax loophole used by wealthy filers.